CBSTF
Price
$0.12
Change
-$0.01 (-7.69%)
Updated
Sep 5 closing price
Capitalization
61.7M
GTBIF
Price
$8.27
Change
+$0.36 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.92B
Interact to see
Advertisement

CBSTF vs GTBIF

Header iconCBSTF vs GTBIF Comparison
Open Charts CBSTF vs GTBIFBanner chart's image
THE CANNABIST COMPANY HOLDINGS
Price$0.12
Change-$0.01 (-7.69%)
Volume$373.66K
Capitalization61.7M
Green Thumb Industries
Price$8.27
Change+$0.36 (+4.55%)
Volume$211.33K
Capitalization1.92B
CBSTF vs GTBIF Comparison Chart in %
Loading...
CBSTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBSTF vs. GTBIF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBSTF is a Hold and GTBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CBSTF: $0.12 vs. GTBIF: $8.27)
Brand notoriety: CBSTF and GTBIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CBSTF: 41% vs. GTBIF: 32%
Market capitalization -- CBSTF: $61.7M vs. GTBIF: $1.92B
CBSTF [@Pharmaceuticals: Generic] is valued at $61.7M. GTBIF’s [@Pharmaceuticals: Generic] market capitalization is $1.92B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBSTF’s FA Score shows that 0 FA rating(s) are green whileGTBIF’s FA Score has 1 green FA rating(s).

  • CBSTF’s FA Score: 0 green, 5 red.
  • GTBIF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CBSTF and GTBIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBSTF’s TA Score shows that 3 TA indicator(s) are bullish while GTBIF’s TA Score has 4 bullish TA indicator(s).

  • CBSTF’s TA Score: 3 bullish, 6 bearish.
  • GTBIF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GTBIF is a better buy in the short-term than CBSTF.

Price Growth

CBSTF (@Pharmaceuticals: Generic) experienced а -10.76% price change this week, while GTBIF (@Pharmaceuticals: Generic) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.92B) has a higher market cap than CBSTF($61.7M). CBSTF YTD gains are higher at: 87.273 vs. GTBIF (1.224). GTBIF has higher annual earnings (EBITDA): 338M vs. CBSTF (-15.44M). GTBIF has more cash in the bank: 177M vs. CBSTF (15.5M). CBSTF has less debt than GTBIF: CBSTF (444M) vs GTBIF (523M). GTBIF has higher revenues than CBSTF: GTBIF (1.15B) vs CBSTF (385M).
CBSTFGTBIFCBSTF / GTBIF
Capitalization61.7M1.92B3%
EBITDA-15.44M338M-5%
Gain YTD87.2731.2247,130%
P/E RatioN/A75.18-
Revenue385M1.15B33%
Total Cash15.5M177M9%
Total Debt444M523M85%
FUNDAMENTALS RATINGS
CBSTF vs GTBIF: Fundamental Ratings
CBSTF
GTBIF
OUTLOOK RATING
1..100
7670
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9990
PRICE GROWTH RATING
1..100
3543
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBSTF's Valuation (44) in the null industry is somewhat better than the same rating for GTBIF (85). This means that CBSTF’s stock grew somewhat faster than GTBIF’s over the last 12 months.

CBSTF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that CBSTF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (90) in the null industry is in the same range as CBSTF (99). This means that GTBIF’s stock grew similarly to CBSTF’s over the last 12 months.

CBSTF's Price Growth Rating (35) in the null industry is in the same range as GTBIF (43). This means that CBSTF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for CBSTF (100). This means that GTBIF’s stock grew significantly faster than CBSTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBSTFGTBIF
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CBSTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRFEF0.06N/A
N/A
Harfang Expl Inc.
BBXIB5.00N/A
N/A
BBX Capital, Inc.
BUHPF4.85N/A
N/A
Bumrungrad Hospital Public Co., Ltd.
IPHLF4.42N/A
N/A
IPH LTD.
CAJFF28.50N/A
N/A
Canon, Inc.

CBSTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBSTF has been loosely correlated with GTBIF. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CBSTF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBSTF
1D Price
Change %
CBSTF100%
-1.75%
GTBIF - CBSTF
59%
Loosely correlated
+4.55%
TSNDF - CBSTF
57%
Loosely correlated
+13.08%
CURLF - CBSTF
56%
Loosely correlated
+1.79%
VRNOF - CBSTF
55%
Loosely correlated
+5.51%
TCNNF - CBSTF
55%
Loosely correlated
+4.55%
More

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with TCNNF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+4.55%
TCNNF - GTBIF
83%
Closely correlated
+4.55%
CURLF - GTBIF
82%
Closely correlated
+1.79%
VRNOF - GTBIF
80%
Closely correlated
+5.51%
TSNDF - GTBIF
78%
Closely correlated
+13.08%
CRLBF - GTBIF
71%
Closely correlated
+5.26%
More